About SUTUREGARD Medical
SUTUREGARD Medical is a private company based in Corvallis, Oregon. It has reported $4,007,920 raised in six offerings on Form D since September 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jul 31, 2024 | $2,970,000fully sold | 1 | $2.9M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 22, 2022 | Jan 4, 2023 | $7,920of $67,320 target | 1 | $7,920 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 15, 2021 | Sep 17, 2021 | $400,000of $650K target | 12 | $33,333 | EquityRule 506(b) | Form D ↗ |
| Apr 19, 2021 | Apr 30, 2021 | $30,000fully sold | 1 | $30,000 | EquityRule 506(b) | Form D ↗ |
| Apr 22, 2020 | Apr 30, 2020amended Jan 14, 2021 | $550,000of $650K target | 20 | $27,500 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 18, 2018 | Sep 27, 2018 | $50,000of $545K target | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $4,007,920 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SUTUREGARD Medical's Form D filed Jul 31, 2024.
DL
Dan Ladizinsky
Executive officer, director and promoter
JO
Jon Olson
Executive officer, director and promoter
BL
Bill Lear
President and director
JA
Jen Akeroyd
Executive officer, director and promoter
Earlier filings also listed Ryan Egeland (director, last listed Jan 2023).